ロード中...
Prognostic and clinicopathological significance of MLKL expression in cancer patients: a meta-analysis
BACKGROUND: MLKL is the most important executor of necroptosis pathway. Recent studies have demonstrated that MLKL could serve as a potential prognostic biomarker for cancer patients. However, most studies reported so far are limited in discrete outcome and sample size. METHODS: We systematically se...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6044038/ https://ncbi.nlm.nih.gov/pubmed/30005626 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4655-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|